On Friday, CalAmp Corp. (NASDAQ:CAMP)’s shares declined -6.48% to $20.34.
CalAmp Corp. (CAMP) declared that it has attained privately held Crashboxx™, an early stage technology company focused on insurance telematics applications across the entire auto insurance lifecycle, from driver risk assessment through claims processing automation. Consideration for the acquisition was $1.5 million in upfront cash and future earn-out payments based on post-acquisition sales.
CalAmp Corp. develops and markets wireless communications products and solutions for various applications worldwide. It operates in two segments, Wireless DataCom and Satellite. The Wireless DataCom segment offers solutions for mobile resource administration applications, machine-to-machine communications space, and other emerging markets that require connectivity anytime and anywhere.
Cavium Inc (NASDAQ:CAVM)’s shares dropped -65.63% to $65.63.
Cavium Inc (CAVM) a leading provider of products that enable secure and intelligent processing for enterprise, data center, wired and wireless networking will demonstrate its 48-core, dual-socket capable ThunderX_NT™ family of ARMv8-A based processors with integrated security, networking and virtual flow accelerators. The demonstration will be showcased at Cavium’s booth #2027 during INTEROP Conference, April 28-30th at the Mandalay Bay Convention Center, Las Vegas.
Network Functions Virtualization (NFV) provides a standard-based approach to virtualizing a range of networking and telecom applications, thus enabling them to utilize common commercial off-the-shelf (COTS) hardware. Networking applications such as virtual application delivery controller (vADC), virtual unified threat administration (vUTM), virtual router (vRouter), and virtual wireless LAN controller (vWLAN) are startning to be deployed in NFV frameworks. However, the traditional processors used in COTS platforms lack the required packet throughput, low latency, integrated security and end-to-end virtualization resulting in poor TCO. This drives the need for a new generation of workload-optimized processor solutions that eliminates the bottleneck of current software only implementations.
Cavium, Inc. designs, develops, and markets semiconductor processors for intelligent and secure networks in United States and internationally. It offers integrated semiconductor processors for wired and wireless networking, communications, storage, cloud, wireless, security, video, and connected home and office applications.
At the end of Friday’s trade, Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)‘s shares dipped -6.25% to $0.750.
Oncolytics Biotech, Inc. (USA) (ONCY) declared that the U.S. Food and Drug Administration (FDA) has granted an Orphan Drug Designation (ODD) for its lead product candidate, REOLYSIN®, for the treatment of malignant glioma. The Company applied for an ODD for pediatric high grade gliomas (HGG), however the FDA granted an ODD for the broader indication of malignant glioma in patients of all ages. In three previous brain cancer studies counting gliomas, REOLYSIN® has been shown to infect a variety of brain tumors when delivered intravenously.
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a cancer therapeutic that is in various clinical trials for human use.
Stratasys, Ltd. (NASDAQ:SSYS), ended its Friday’s trading session with -6.04% loss, and closed at $51.28.
Stratasys, Ltd. (SSYS) declared the introduction of the new Xtend 500 Fortus Plus, a high-volume filament package for Fortus 3D Production Systems. Stratasys also launched the industrial scale Objet1000 Plus 3D Production System which offers extra-large print size and accelerated speeds for demanding manufacturing applications counting aerospace, automotive, medical devices, and consumer products in addition to for service bureaus and universities.
Designed for reliable and unattended high-volume use, each Xtend 500 box contains 500 cubic inches of FDM thermoplastic material, delivering more than five times the output of standard canisters. When two material boxes are loaded into a Fortus 3D Production System, users can expect up to 400 hours of unattended run time and up to 1,000 cubic inches of material use.
Stratasys Ltd. provides additive manufacturing (AM) solutions for the creation of parts used in the processes of designing and manufacturing products; and for the direct manufacture of end parts. Its AM systems utilize its patented fused deposition modeling and inkjet-based PolyJet technologies to enable the production of prototypes, tools used for production and manufactured goods directly from three-dimensional (3D) CAD files or other 3D content.
Stratasys Ltd. provides additive manufacturing (AM) solutions for the creation of parts used in the processes of designing and manufacturing products; and for the direct manufacture of end parts. Its AM systems utilize its patented fused deposition modeling and inkjet-based PolyJet technologies to enable the production of prototypes, tools used for production and manufactured goods directly from three-dimensional (3D) CAD files or other 3D content.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
